Results are best when 2 cadavers are used, with each supplying 2 or 3 infusions of islet cells, followed by a posttransplantation immunosuppression regimen consisting of an anti-IL-2 receptor antibody (basiliximab), tacrolimus, and sirolimus (Edmonton protocol); corticosteroids are used sparingly because they cause hyperglycemia.